Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Long-Term Deferred Tax (2016 - 2017)

Wave Life Sciences (WVE) has disclosed Long-Term Deferred Tax for 3 consecutive years, with $774000.0 as the latest value for Q2 2017.

  • For the quarter ending Q2 2017, Long-Term Deferred Tax rose 303.12% year-over-year to $774000.0, compared with a TTM value of $774000.0 through Jun 2017, up 303.12%, and an annual FY2016 reading of $560000.0, up 191.67% over the prior year.
  • Long-Term Deferred Tax was $774000.0 for Q2 2017 at Wave Life Sciences, roughly flat from $774000.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $774000.0 in Q1 2017 and bottomed at $32000.0 in Q3 2016.
  • Average Long-Term Deferred Tax over 3 years is $388000.0, with a median of $192000.0 recorded in 2015.
  • The sharpest move saw Long-Term Deferred Tax skyrocketed 191.67% in 2016, then soared 303.12% in 2017.
  • Year by year, Long-Term Deferred Tax stood at $192000.0 in 2015, then skyrocketed by 191.67% to $560000.0 in 2016, then skyrocketed by 38.21% to $774000.0 in 2017.
  • Business Quant data shows Long-Term Deferred Tax for WVE at $774000.0 in Q2 2017, $774000.0 in Q1 2017, and $560000.0 in Q4 2016.